NDC 25021-263 – Doxorubicin Hydrochloride Liposome
Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Intravenous
Product NDC25021-263
Product details
- Brand name
- Doxorubicin Hydrochloride Liposome
- Generic name
- Doxorubicin Hydrochloride
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- Injection, Suspension, Liposomal
- Route
- Intravenous
- Marketing category
- ANDA · ANDA219881
- Marketed since
- March 1, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anthracycline Topoisomerase Inhibitor
Active ingredients
- Doxorubicin Hydrochloride 2 mg/mL
Uses, dosage, side effects and warnings for Doxorubicin Hydrochloride Liposome →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 25021-263-10 | 1 VIAL in 1 CARTON (25021-263-10) / 10 mL in 1 VIAL | Mar 1, 2026 |
| 25021-263-25 | 1 VIAL in 1 CARTON (25021-263-25) / 25 mL in 1 VIAL | Mar 1, 2026 |